Literature DB >> 19909261

Whole genome expression as a quantitative trait.

John Hardy1, Danyah Trabzuni, Mina Ryten.   

Abstract

Surprisingly, whole genome analyses of complex human neurological and psychiatric disorders have revealed that many genetic risk factors are likely to influence gene expression rather than alter protein sequences. Previous analyses of neurological diseases have shown that genetic variability in gene expression levels of deposited proteins influence disease risk. With this background, we have embarked on a comprehensive project to determine the effects of common genetic variability on whole genome gene expression.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19909261     DOI: 10.1042/BST0371276

Source DB:  PubMed          Journal:  Biochem Soc Trans        ISSN: 0300-5127            Impact factor:   5.407


  7 in total

Review 1.  Using DNA methylation to understand biological consequences of genetic variability.

Authors:  Dena G Hernandez; Andrew B Singleton
Journal:  Neurodegener Dis       Date:  2011-11-26       Impact factor: 2.977

Review 2.  Polygenic Risk Scores in Clinical Psychology: Bridging Genomic Risk to Individual Differences.

Authors:  Ryan Bogdan; David A A Baranger; Arpana Agrawal
Journal:  Annu Rev Clin Psychol       Date:  2018-05-07       Impact factor: 18.561

3.  Monoacylglycerol lipase (MGLL) polymorphism rs604300 interacts with childhood adversity to predict cannabis dependence symptoms and amygdala habituation: Evidence from an endocannabinoid system-level analysis.

Authors:  Caitlin E Carey; Arpana Agrawal; Bo Zhang; Emily D Conley; Louisa Degenhardt; Andrew C Heath; Daofeng Li; Michael T Lynskey; Nicholas G Martin; Grant W Montgomery; Ting Wang; Laura J Bierut; Ahmad R Hariri; Elliot C Nelson; Ryan Bogdan
Journal:  J Abnorm Psychol       Date:  2015-11

Review 4.  Imaging Genetics and Genomics in Psychiatry: A Critical Review of Progress and Potential.

Authors:  Ryan Bogdan; Betty Jo Salmeron; Caitlin E Carey; Arpana Agrawal; Vince D Calhoun; Hugh Garavan; Ahmad R Hariri; Andreas Heinz; Matthew N Hill; Andrew Holmes; Ned H Kalin; David Goldman
Journal:  Biol Psychiatry       Date:  2017-01-13       Impact factor: 13.382

5.  Genomic microdeletions associated with epilepsy: not a contraindication to resective surgery.

Authors:  Claudia B Catarino; Dalia Kasperavičiūtė; Maria Thom; Gianpiero L Cavalleri; Lillian Martinian; Erin L Heinzen; Thomas Dorn; Thomas Grunwald; Elijah Chaila; Chantal Depondt; Günter Krämer; Norman Delanty; David B Goldstein; Sanjay M Sisodiya
Journal:  Epilepsia       Date:  2011-06-02       Impact factor: 5.864

6.  Quality control parameters on a large dataset of regionally dissected human control brains for whole genome expression studies.

Authors:  Daniah Trabzuni; Mina Ryten; Robert Walker; Colin Smith; Sabaena Imran; Adaikalavan Ramasamy; Michael E Weale; John Hardy
Journal:  J Neurochem       Date:  2011-09-20       Impact factor: 5.372

7.  Antipsychotic pharmacogenomics in first episode psychosis: a role for glutamate genes.

Authors:  J M Stevenson; J L Reilly; M S H Harris; S R Patel; P J Weiden; K M Prasad; J A Badner; V L Nimgaonkar; M S Keshavan; J A Sweeney; J R Bishop
Journal:  Transl Psychiatry       Date:  2016-02-23       Impact factor: 6.222

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.